Anteris Technologies completes partial over-allotment option exercise post-IPO.
Posted on: 14/01/2025
Anteris Technologies announces U.S. IPO pricing at $6.00 per share.
Posted on: 13/12/2024
Anteris Technologies confirms Nasdaq IPO schedule for Holdco shares.
Anteris Technologies Global Corp. launches U.S. IPO for 14.8 million shares.
Posted on: 09/12/2024
Anteris Technologies files for U.S. IPO, aiming to list on Nasdaq.
Posted on: 24/11/2024
Anteris Technologies announces court-approved dispatch of supplementary scheme booklet.
Posted on: 12/11/2024
Anteris Technologies delays US IPO and Nasdaq listing timetable.
Posted on: 29/09/2024
Anteris Technologies announces positive clinical data and significant financial milestones.
Posted on: 31/07/2024
Anteris Technologies completes a $30 million placement to fund DurAVR THV development.
Posted on: 23/07/2024
Anteris Technologies halts trading pending capital raising announcement.
Posted on: 21/07/2024
Anteris Technologies halts trading pending a future announcement.